Evidence map›Paper›PMID 31541522›Full record

ArticleTransplant infectious disease : an official journal of the Transplantation Society2019

Using machine learning to estimate survival curves for patients receiving an increased risk for disease transmission heart, liver, or lung versus waiting for a standard organ.

Ethan Mark, David Goldsman, Pinar Keskinocak, Joel Sokol

Abstract readValidation Study
In one paragraph

Article in Transplant infectious disease : an official journal of the Transplantation Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Understanding Machine Learning Applications in Lung Transplantation: A Narrative Review.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ethan MarkH. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, GA, USA.ORCID https://orcid.org/0000-0002-6404-9140
David GoldsmanH. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, GA, USA.ORCID https://orcid.org/0000-0001-9033-8475
Pinar KeskinocakH. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, GA, USA.ORCID https://orcid.org/0000-0003-2686-546X
Joel SokolH. Milton Stewart School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, GA, USA.ORCID https://orcid.org/0000-0001-8228-8359

Funding

Arnold FoundationCarlos and Marguerite Mason Trust
6 · The paper itself

Abstract

introductionOver 19% of deceased organ donors are labeled increased risk for disease transmission (IRD) for viral blood-borne disease transmission. Many potential organ recipients need to decide between accepting an IRD organ offer and waiting for a non-IRD organ.

methodsUsing machine learning and simulation, we built transplant and waitlist survival models and compared the survival for patients accepting IRD organ offers or waiting for non-IRD organs for the heart, liver, and lung. The simulation consisted of generating 20 000 different scenarios of a recipient either receiving an IRD organ or waiting and receiving a non-IRD organ.

resultsIn the simulations, the 5-year survival probabilities of heart, liver, and lung recipients who accepted IRD organ offers increased on average by 10.2%, 12.7%, and 7.2%, respectively, compared with receiving a non-IRD organ after average wait times (190, 228, and 223 days, respectively). When the estimated waitlist time was at least 5 days for the liver, and 1 day for the heart and lung, 50% or more of the simulations resulted in a higher chance of 5-year survival when the patient received an IRD organ versus when the patient remained on the waitlist. We also developed a simple equation to estimate the benefits, in terms of 5-year survival probabilities, of receiving an IRD organ versus waiting for a non-IRD organ, for a particular set of recipient/donor characteristics.

conclusionFor all three organs, the majority of patients are predicted to have higher 5-year survival accepting an IRD organ offer compared with waiting for a non-IRD organ.

Indexed as

Models, StatisticalSurvival AnalysisAllograftsComputer SimulationDonor SelectionHeart DiseasesHumansLiver DiseasesLung DiseasesMachine LearningOrgan TransplantationRisk AssessmentRisk FactorsTime FactorsUnited StatesVirus DiseasesCox proportional hazards modelHBV transmissionHCV transmissionheart transplantationHIV transmissionincreased risk for disease transmission donorliver transplantationlung transplantationsurvival analysis

Identifiers

PMID31541522
PMCPMC9285951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.